CS178073B2 - - Google Patents

Info

Publication number
CS178073B2
CS178073B2 CS7726A CS772670A CS178073B2 CS 178073 B2 CS178073 B2 CS 178073B2 CS 7726 A CS7726 A CS 7726A CS 772670 A CS772670 A CS 772670A CS 178073 B2 CS178073 B2 CS 178073B2
Authority
CS
Czechoslovakia
Application number
CS7726A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691957750 external-priority patent/DE1957750A1/de
Priority claimed from DE19702047805 external-priority patent/DE2047805A1/de
Priority claimed from DE19702047804 external-priority patent/DE2047804A1/de
Priority claimed from DE19702047802 external-priority patent/DE2047802A1/de
Priority claimed from DE19702047803 external-priority patent/DE2047803A1/de
Application filed filed Critical
Publication of CS178073B2 publication Critical patent/CS178073B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS7726A 1969-11-17 1970-11-16 CS178073B2 (cs)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19691957750 DE1957750A1 (de) 1969-11-17 1969-11-17 Neue Hydroxycrotonsaeuren
DE19702047805 DE2047805A1 (en) 1970-09-29 1970-09-29 Substd hydroxy crotonic acids
DE19702047804 DE2047804A1 (en) 1970-09-29 1970-09-29 Substd hydroxy crotonic acids
DE19702047802 DE2047802A1 (en) 1970-09-29 1970-09-29 Substd hydroxy crotonic acids
DE19702047803 DE2047803A1 (en) 1970-09-29 1970-09-29 Substd hydroxy crotonic acids

Publications (1)

Publication Number Publication Date
CS178073B2 true CS178073B2 (cs) 1977-08-31

Family

ID=27510074

Family Applications (1)

Application Number Title Priority Date Filing Date
CS7726A CS178073B2 (cs) 1969-11-17 1970-11-16

Country Status (18)

Country Link
US (1) US3655743A (cs)
JP (1) JPS4948311B1 (cs)
AT (1) AT303018B (cs)
BE (1) BE759053A (cs)
BG (1) BG20561A3 (cs)
CA (1) CA984408A (cs)
CH (1) CH537895A (cs)
CS (1) CS178073B2 (cs)
DK (1) DK126644B (cs)
FI (1) FI52334C (cs)
FR (1) FR2073368B1 (cs)
GB (1) GB1322370A (cs)
IE (1) IE34744B1 (cs)
IL (1) IL35656A (cs)
NL (1) NL7016745A (cs)
NO (1) NO134462C (cs)
SE (1) SE360649B (cs)
SU (1) SU474134A3 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205732A1 (de) * 1972-02-08 1973-08-16 Thomae Gmbh Dr K Neue 4-(4-biphenylyl)-butensaeurederivate
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
GB1498903A (en) * 1974-03-25 1978-01-25 Fabre Sa Pierre Aromatic keto-acids and their derivatives
US4096338A (en) * 1974-07-27 1978-06-20 Nisshin Flour Milling Co., Ltd. Butenoic and pyruvic acid derivatives
US4151302A (en) * 1975-06-28 1979-04-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Araliphatic dihalogen compounds composition and method of use
FR2332279A1 (fr) * 1975-11-19 1977-06-17 Nativelle Sa Ets Procede d'oxydation des alcaloides du quinquina
US4239912A (en) * 1978-12-08 1980-12-16 American Cyanamid Company Process for resolving DL-Mandelic acid with novel 2-benzylamino-1-butanols
DE3909378A1 (de) * 1989-03-22 1990-09-27 Bayer Ag Substituierte biphenyle
GB2349880A (en) 1999-05-10 2000-11-15 Secr Defence (Thio)morpholinium salts having SHG activity
WO2007096647A2 (en) * 2006-02-27 2007-08-30 Sterix Limited Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer

Also Published As

Publication number Publication date
BG20561A3 (cs) 1975-12-05
IL35656A0 (en) 1971-01-28
SU474134A3 (ru) 1975-06-14
US3655743A (en) 1972-04-11
BE759053A (fr) 1971-05-17
CA984408A (en) 1976-02-24
FI52334C (fi) 1977-08-10
NL7016745A (cs) 1971-05-19
SE360649B (cs) 1973-10-01
NO134462B (cs) 1976-07-05
AT303018B (de) 1972-11-10
IE34744B1 (en) 1975-08-06
FR2073368A1 (cs) 1971-10-01
CH537895A (de) 1973-06-15
DK126644B (da) 1973-08-06
GB1322370A (en) 1973-07-04
IL35656A (en) 1974-03-14
FR2073368B1 (cs) 1974-10-11
FI52334B (cs) 1977-05-02
NO134462C (cs) 1976-10-13
IE34744L (en) 1971-05-17
JPS4948311B1 (cs) 1974-12-20

Similar Documents

Publication Publication Date Title
AU465413B2 (cs)
FI52334B (cs)
AU450150B2 (cs)
AU442375B2 (cs)
AU470301B1 (cs)
AU427401B2 (cs)
AU442538B2 (cs)
AU442535B2 (cs)
AU428074B2 (cs)
AU442463B2 (cs)
AU470661B1 (cs)
AU442380B2 (cs)
CS150492B1 (cs)
AU4949169A (cs)
AU4923469A (cs)
CS152752B1 (cs)
AU5109569A (cs)
AU5598769A (cs)
CH562335A (cs)
BE734433A (cs)
AU5066368A (cs)
AU5006968A (cs)
AU4953367A (cs)
BE735921A (cs)
AU4815038A (cs)